Therefore, additional validation studies are needed to determine if the interactions among UNC5C, CNTN6, PLXNA4, and EPHB2 genes can influence AD onset in other, larger-scale, datasets with time-to-event information on ages of AD onset. Here, PLXNA4 is linked to Alzheimer disease.